Ironwood Pharmaceuticals' (IRWD) shares rose 9% in premarket trading on Friday as the company raised its adjusted core earnings guidance to greater than $105 million for 2025.

Q1 2025 Management View CEO Andres Campos highlighted the challenges of global volatility, affecting operations in Mexico, ...

Reports Q1 revenue $8.12B, consensus $8.16B. “We had a consistent start to the year, aligned with our objectives for 2025. We are seeing good ...

Narrows FY25 free cash flow view to $17.5B-$18.0B from $17.3B-$18.0B. Affirms FY25 postpaid net customer additions of 5.5M-6.0M.Stay Ahead of ...

Formula One's (FWONA) growth under Liberty Media has been impressive, nearly doubling revenue and improving profitability.

CMS Info Systems and Sharda Motors—fit Ramdeo Agrawal's 25-25-25 rule, showing strong profit growth, high RoCE, and ...